Anti-rheumatic_JJ
compound_NN
aurothioglucose_NN
inhibits_VBZ
tumor_NN
necrosis_NN
factor-alpha-induced_JJ
HIV-1_NN
replication_NN
in_IN
latently_RB
infected_VBN
OM10_NN
.1_CD
and_CC
Ach2_NN
cells_NNS
._.

NF-kappaB_NN
is_VBZ
a_DT
potent_JJ
cellular_JJ
activator_NN
of_IN
HIV-1_NN
gene_NN
expression_NN
._.

Down-regulation_NN
of_IN
NF-kappaB_NN
activation_NN
is_VBZ
known_VBN
to_TO
inhibit_VB
HIV_NN
replication_NN
from_IN
the_DT
latently_RB
infected_VBN
cells_NNS
._.

Gold_NN
compounds_NNS
have_VBP
been_VBN
effectively_RB
used_VBN
for_IN
many_JJ
decades_NNS
in_IN
the_DT
treatment_NN
of_IN
rheumatoid_JJ
arthritis_NN
._.

We_PRP
previously_RB
reported_VBD
that_IN
gold_NN
compounds_NNS
,_,
especially_RB
aurothioglucose_NN
-LRB-_-LRB-
AuTG_NN
-RRB-_-RRB-
containing_VBG
monovalent_JJ
gold_NN
ion_NN
,_,
inhibited_VBD
the_DT
DNA-binding_NN
of_IN
NF-kappaB_NN
in_FW
vitro_FW
._.

In_IN
this_DT
report_NN
we_PRP
have_VBP
examined_VBN
the_DT
efficacy_NN
of_IN
the_DT
gold_NN
compound_NN
AuTG_NN
as_IN
an_DT
inhibitor_NN
of_IN
HIV_NN
replication_NN
in_IN
latently_RB
infected_VBN
OM10_NN
.1_CD
and_CC
Ach2_NN
cells_NNS
._.

Tumor_NN
necrosis_NN
factor_NN
-LRB-_-LRB-
TNF_NN
-RRB-_-RRB-
-_:
alpha-induced_JJ
HIV-1_NN
replication_NN
in_IN
OM10_NN
.1_CD
or_CC
Ach2_NN
cells_NNS
was_VBD
significantly_RB
inhibited_VBN
by_IN
non-cytotoxic_JJ
doses_NNS
of_IN
AuTG_NN
-LRB-_-LRB-
&gt;_JJR
10_CD
microM_NN
in_IN
OM10_NN
.1_CD
cells_NNS
and_CC
&gt;_JJR
25_CD
F.M_NN
in_IN
Ach2_NN
cells_NNS
-RRB-_-RRB-
,_,
while_IN
25_CD
microM_NN
of_IN
the_DT
counter-anion_JJ
thioglucose_NN
-LRB-_-LRB-
TG_NN
-RRB-_-RRB-
or_CC
gold_NN
compound_NN
containing_VBG
divalent_JJ
gold_NN
ion_NN
,_,
HAuCl3_NN
,_,
had_VBD
no_DT
effect_NN
._.

The_DT
effect_NN
of_IN
AuTG_NN
on_IN
NF-kappaB-dependent_JJ
gene_NN
expression_NN
was_VBD
confirmed_VBN
by_IN
a_DT
transient_JJ
CAT_NN
assay_NN
._.

Specific_JJ
staining_NN
as_RB
well_RB
as_IN
electron_NN
microscopic_JJ
examinations_NNS
revealed_VBD
the_DT
accumulation_NN
of_IN
metal_JJ
gold_NN
in_IN
the_DT
cells_NNS
,_,
supporting_VBG
our_PRP$
previous_JJ
hypothesis_NN
that_IN
gold_NN
ions_NNS
could_MD
block_VB
NF-kappaB-DNA_JJ
binding_NN
by_IN
a_DT
redox_NN
mechanism_NN
._.

These_DT
observations_NNS
indicate_VBP
that_IN
the_DT
monovalent_JJ
gold_NN
compound_NN
AuTG_NN
is_VBZ
a_DT
potentially_RB
useful_JJ
drug_NN
for_IN
the_DT
treatment_NN
of_IN
patients_NNS
infected_VBN
with_IN
HIV_NN
._.

